Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05242250 · ClinicalTrials.gov registry record
Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial Fibrillation (DYNAMIC AF Registry)
A clinical trial, sponsored by Heart Rhythm Clinical and Research Solutions.
- Terminated
- Registry status
- 392
- Enrollment target
NCT05242250: Clinical Trial study, sponsored by Heart Rhythm Clinical and Research Solutions.
NCT05242250 is a clinical trial that was terminated before completion, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 392 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05242250 was terminated before completion, sponsored by Heart Rhythm Clinical and Research Solutions.
- TERMINATED
- Registry status
- 392 participants
- Enrollment target
Study Summary
DYNAMIC AF is an observational, prospective, multi-center, non-randomized registry designed to obtain real world clinical experience of radiofrequency (RF) ablation for the treatment of paroxysmal (PAF) and persistent (PsAF) atrial fibrillation ablation. Patient assessments will occur at pre- procedure, procedure, 12 weeks, 6 months and 1 year post ablation.
Primary Outcome
Long term safety is assessed by collection of procedure or device related complications.
Interventions
- DEVICE Catheter Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2022-01-10 |
| Est. Completion | 2023-12-31 |
Why NCT05242250 stopped before completion
NCT05242250 is an observational study that tracks outcomes without assigning an intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Catheter Ablation is the first listed.
NCT05242250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05242250 about?
NCT05242250 is a clinical study titled "Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial Fibrillation (DYNAMIC AF Registry)". DYNAMIC AF is an observational, prospective, multi-center, non-randomized registry designed to obtain real world clinical experience of radiofrequency (RF) ablation for the treatment of paroxysmal (PAF) and persistent (PsAF) atrial fibrillation ablation. Patient assessments will occur at pre- proced...
What is the current status of trial NCT05242250?
This trial is currently terminated. The enrollment target is 392 participants. The study started on 2022-01-10. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05242250?
The interventions under investigation include: Catheter Ablation (DEVICE).
Who is sponsoring clinical trial NCT05242250?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI